Table 3.
|
Visit 1 |
Visit 2 |
Visit 2 to visit 1 ratio |
|||
---|---|---|---|---|---|---|
Plasma analyte | ρ | p | ρ | p | ρ | p |
IL-10 | −0.13 | 0.32 | −0.28 | 0.03 | −0.17 | 0.19 |
IL-18 | −0.27 | 0.04 | −0.25 | 0.05 | 0.04 | 0.75 |
Soluble CD30 | −0.40 | <0.01 | −0.35 | <0.01 | 0.09 | 0.51 |
CD4+ T cell counts at two separate visits are converted to a ratio (visit 2 to visit 1) before being treated as an alternative outcome measure. Spearman correlation (ρ) and associated p value are shown for each of the three analytes at both visits and for the ratio of these analytes (also visit 2 to visit 1).